Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$17.23 - $21.71 $33,098 - $41,704
-1,921 Reduced 46.67%
2,195 $43,000
Q1 2023

May 08, 2023

BUY
$18.08 - $24.55 $18,640 - $25,311
1,031 Added 33.42%
4,116 $77,000
Q4 2022

Feb 13, 2023

BUY
$20.4 - $24.73 $62,933 - $76,292
3,085 New
3,085 $69,000
Q3 2018

Nov 13, 2018

BUY
$65.0 - $82.15 $269,815 - $341,004
4,151 Added 18.01%
27,200 $2.05 Million
Q2 2018

Aug 10, 2018

BUY
$27.2 - $74.35 $626,932 - $1.71 Million
23,049 New
23,049 $1.65 Million

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $420M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.